Loading...
SeniorFull-time
Salary Range
$66,300 - $89,700 /year
This salary is estimated based on similar roles. The actual salary may vary.
About the Role
The Manager, Price Forecasting is responsible for Humira Gross-to-Net (GTN) sales planning and reporting, estimating rebates/discounts, and providing ad hoc financial analysis. This role provides financial leadership to the Market Access and Brand team in development of Plans, LRPs, and LBEs.
Key Responsibilities
- →Support the planning and reporting for Humira rebates, discounts, and utilization for all financial cycles.
- →Prepare all required schedules and leverage financial systems (BPC, QlikView, PowerBI) for monthly close and financial cycles.
- →Work closely with Market Access and Pricing to review the Gross-to-Net (GTN) forecast.
- →Understand and discuss all price related variances for month-end close and Plan/LRP/LBE.
- →Conduct price scenario analysis for various planning cycles.
- →Provide support for the Humira reserve balance sheet process.
- →Work with forecasting and commercial finance to present a consolidated net sales message.
- →Manage a complex erosion model to forecast channel-based demand in close partnership with Volume Forecasting and multiple business partners for data feeds.
Requirements
- ✓Financial analysis experience with pharmaceutical pricing and rebates
- ✓Proficiency in financial systems including BPC, QlikView, and PowerBI
- ✓Strong analytical and problem-solving skills
- ✓Experience with sales planning and forecasting processes
- ✓Ability to work independently and manage complex financial models
Free to sign up. Takes 30 seconds.
About Abbvie
Abbvie is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies. Headquartered in North Chicago, Illinois, the company was founded in 2013 following the spin-off of Abbott Laboratories' pharmaceutical division. Abbvie operates at the forefront of the biotechnology and pharmaceutical industries, focusing on addressing complex diseases and improving patient outcomes through scientific advancement. The company's primary products include treatments for immunology, oncology, and neurology, with its flagship drug, Humira, being one of the best-selling medications globally. Abbvie is known for its robust pipeline of investigational therapies, leveraging cutting-edge research and clinical trials to bring novel treatments to market. Its target audience includes patients, healthcare providers, and payers, with a particular emphasis on those suffering from chronic and life-threatening conditions. Key features of Abbvie's offerings include targeted therapies, personalized medicine approaches, and a commitment to regulatory compliance and safety. Abbvie has achieved significant milestones, including maintaining a leading position in the global pharmaceutical market and generating substantial revenue through its innovative portfolio. The company's unique value proposition lies in its dedication to scientific excellence and patient-centric care, supported by a strong pipeline and strategic investments in research and development. Abbvie's market position is further strengthened by its global reach, collaborative partnerships, and a reputation for delivering transformative therapies.
